Nobel
prize for medicine goes to cancer therapy
By Michelle RobertsHealth editor, BBC News
online
Two
scientists who discovered how to fight cancer using the body's immune system
have won the 2018 Nobel Prize for physiology or medicine.
The
work, by Professor James P Allison from the US
and Professor Tasuku Honjo from Japan ,
has led to treatments for advanced, deadly skin cancer.
Immune
checkpoint therapy has revolutionised cancer treatment, said the prize-giving Swedish Academy .
Experts
say it has proved to be "strikingly effective".
Prof
Allison, of the University of Texas , and Prof Honjo, of Kyoto University ,
will share the Nobel prize sum of nine million Swedish kronor - about $1.01
million or 870,000 euros.
Accepting
the prize, Tasuku Honjo told reporters: "I want to continue my research
... so that this immune therapy will save more cancer patients than ever."
Prof
Allison said: "It's a great, emotional privilege to meet cancer patients
who've been successfully treated with immune checkpoint blockade. They are
living proof of the power of basic science, of following our urge to learn and
to understand how things work."
Treating
the untreatable
Our
immune system protects us from disease, but it has built-in safeguards to stop
it from attacking our own tissue.
Some
cancers can take advantage of those "brakes" and dodge the attack
too.
Allison
and Honjo, now both in their 70s, discovered a way to unleash our immune cells
to attack tumours by turning off proteins that put the brakes on.
And
that led to the development of new drugs which now offer hope to patients with
advanced and previously untreatable cancer.
Immune
checkpoint therapy is being used by the NHS to treat people with the most
serious form of skin cancer, melanoma.
It
doesn't work for everyone, but for some patients it appears to have
worked incredibly
well, getting rid of the tumour entirely, even after it had started to
spread around the body.
Such
remarkable results had never been seen before for patients like these.
Doctors
have also been using the treatment to help some people with advanced lung
cancer.
Prof
Charles Swanton, from Cancer Research UK , congratulated the prize
winners, saying: "Thanks to this groundbreaking work, our own immune
system's innate power against cancer has been realised and harnessed into
treatments that continue to save the lives of patients. For cancers such as
advanced melanoma, lung, and kidney, these immune-boosting drugs have
transformed the outlook for many patients who had run out of options.
"The
booming field of immunotherapy that these discoveries have precipitated is
still relatively in its infancy, so it's exciting to consider how this research
will progress in the future and what new opportunities will arise."
Medicine
is the first of the Nobel Prizes awarded each year.
The
literature prize will not be handed out this year, after the awarding body
was affected by
a sexual misconduct scandal.